Mithra Pharmaceuticals SA (MITPF)
6.75
0.00 (0.00%)
USD |
OTCM |
Nov 22, 16:00
Mithra Pharmaceuticals Debt to Equity Ratio: -19.15 for June 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | -19.15 |
| December 31, 2022 | 5.492 |
| June 30, 2022 | 4.814 |
| December 31, 2021 | 5.077 |
| June 30, 2021 | 1.386 |
| December 31, 2020 | 0.8599 |
| June 30, 2020 | 0.1356 |
| December 31, 2019 | 0.1541 |
| June 30, 2019 | 0.4172 |
| Date | Value |
|---|---|
| December 31, 2018 | 0.1946 |
| June 30, 2018 | 1.082 |
| December 31, 2017 | 0.2761 |
| June 30, 2017 | 0.1896 |
| December 31, 2016 | 0.5047 |
| June 30, 2016 | 0.0748 |
| December 31, 2015 | 0.1639 |
| June 30, 2015 | 0.0994 |
| December 31, 2014 | 0.9455 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-19.15
Minimum
Jun 2023
5.492
Maximum
Dec 2022
-0.1541
Average
1.123
Median
Debt to Equity Ratio Benchmarks
| Galapagos NV | 0.00 |
| UCB SA | 0.3178 |
| Nyxoah SA | 0.1866 |
| Celyad Oncology SA | 0.00 |
| MDxHealth SA | 3.022 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 407.25M |
| Total Liabilities (Quarterly) | 416.74M |
| Shareholders Equity (Quarterly) | -9.487M |
| Current Ratio | 1.043 |
| Net Debt Paydown Yield | 1.08% |